Atlas Publishing Co.

Over 18,000+ Readers Of Atlas

The number one way to find multibagger stocks

The number one way to find multibagger stocks

Atlas is the world’s leading independent provider of financial research. Investing doesn't have to be as hard as you think. With our research, you'll discover everything you need to know to make better choices with your money. See how over 18,000 investors are taking control of their wealth.

Atlas is the world’s leading independent provider of financial research. Investing doesn't have to be as hard as you think. With our research, you'll discover everything you need to know to make better choices with your money. See how over 18,000 investors are taking control of their wealth.

Brands we mail our research reports to:

Brands we mail our research reports to:

Brands we mail our research reports to:

Who we are

The top stock publisher built for you.

Half of Americans worry they won't have enough money for the future. We are changing that. We give you direct access to the world’s most valuable market insights—strategies usually reserved for the wealthy.

1,800+

new monthly readers.

98%

time savings

1 Quater

Average time to see positive results.

Want to discover more?

Atlas Publishing is the premier source of world-class research for self-directed investors. We publish four distinct investment advisories and are the exclusive home of Pharma Fortunes.

Who we are

The top stock publisher built for you.

Half of Americans worry they won't have enough money for the future. We are changing that. We give you direct access to the world’s most valuable market insights—strategies usually reserved for the wealthy.

1,800+

new monthly readers.

98%

time savings

1 Quater

Average time to see positive results.

Want to discover more?

Atlas Publishing is the premier source of world-class research for self-directed investors. We publish four distinct investment advisories and are the exclusive home of Pharma Fortunes.

Who we are

The top stock publisher built for you.

Half of Americans worry they won't have enough money for the future. We are changing that. We give you direct access to the world’s most valuable market insights—strategies usually reserved for the wealthy.

1,800+

new monthly readers.

98%

time savings

1 Quater

Average time to see positive results.

Want to discover more?

Atlas Publishing is the premier source of world-class research for self-directed investors. We publish four distinct investment advisories and are the exclusive home of Pharma Fortunes.

Our Services

Our Publishing Research Is Your Portfolio Edge.

Our Publishing Research Is Your Portfolio Edge.

We are the premier source of world-class financial research for self-directed investors. We don’t manage your money. We don’t touch your accounts. We give you the super brain to do it yourself.

Discover

01

Build

02

Deploy

03

Optimize

04

Discover

Discover the hidden windfalls most investors miss—from pre-approval biotech stocks primed for 1,000% gains to "invisible" earnings surprises identified days before the news hits the wire.

Build

Build Portfolio management without the guesswork—arm yourself with the "Super Brain" mathematical certainty.

Deploy

Edge out Wall Street with our proprietary "Earnings ESP," the only tool designed to predict massive earnings beats in advance, allowing you to position yourself for profit while the pros are still sleeping.

Optimize

Optimize your timing with our Atlas Price Response Indicator, which tells you exactly how a stock price is likely to react post-earnings so you never buy at the top or sell too soon.

Book a free call

Discover

01

Build

02

Deploy

03

Optimize

04

Discover

Discover the hidden windfalls most investors miss—from pre-approval biotech stocks primed for 1,000% gains to "invisible" earnings surprises identified days before the news hits the wire.

Build

Build Portfolio management without the guesswork—arm yourself with the "Super Brain" mathematical certainty.

Deploy

Edge out Wall Street with our proprietary "Earnings ESP," the only tool designed to predict massive earnings beats in advance, allowing you to position yourself for profit while the pros are still sleeping.

Optimize

Optimize your timing with our Atlas Price Response Indicator, which tells you exactly how a stock price is likely to react post-earnings so you never buy at the top or sell too soon.

Book a free call

Discover

01

Build

02

Deploy

03

Optimize

04

Discover

Discover the hidden windfalls most investors miss—from pre-approval biotech stocks primed for 1,000% gains to "invisible" earnings surprises identified days before the news hits the wire.

Build

Build Portfolio management without the guesswork—arm yourself with the "Super Brain" mathematical certainty.

Deploy

Edge out Wall Street with our proprietary "Earnings ESP," the only tool designed to predict massive earnings beats in advance, allowing you to position yourself for profit while the pros are still sleeping.

Optimize

Optimize your timing with our Atlas Price Response Indicator, which tells you exactly how a stock price is likely to react post-earnings so you never buy at the top or sell too soon.

Book a free call

What you get

Instant access to the engine that beats the competition.

1. The Atlas Rank System The proprietary tool that rates stocks purely on math. This is the same type of math used by Jim Simons. His Medallion Fund is known for its impressive average annual returns of around 66% since its inception

1. The Atlas Rank System The proprietary tool that rates stocks purely on math. This is the same type of math used by Jim Simons. His Medallion Fund is known for its impressive average annual returns of around 66% since its inception

2. The Price Response Indicator We use Ai to tell you what a stock price is likely to do after an earnings report.

2. The Price Response Indicator We use Ai to tell you what a stock price is likely to do after an earnings report.

3. The "Earnings ESP" (Expected Surprise Prediction) This is our proprietary edge over Wall Street. It determines the likelihood of a massive earnings beat BEFORE the news hits the wire, allowing you to get in before the price explodes.

3. The "Earnings ESP" (Expected Surprise Prediction) This is our proprietary edge over Wall Street. It determines the likelihood of a massive earnings beat BEFORE the news hits the wire, allowing you to get in before the price explodes.

4. Exclusive Access: Pharma Fortunes We are the only place where you can get Pharma Fortunes. This strategy targets small-cap biotech firms seeking FDA approval. These binary events are powerful: we’ve seen them send stocks soaring 1,000% overnight.

4. Exclusive Access: Pharma Fortunes We are the only place where you can get Pharma Fortunes. This strategy targets small-cap biotech firms seeking FDA approval. These binary events are powerful: we’ve seen them send stocks soaring 1,000% overnight.

“There is nothing to fear from the truth... Being truthful, and letting others be truthful with you, allows you to explore your own thoughts and the thoughts of others, which is essential for learning.”

Ray Dalio

Founder of Bridgewater Associates

“There is nothing to fear from the truth... Being truthful, and letting others be truthful with you, allows you to explore your own thoughts and the thoughts of others, which is essential for learning.”

Ray Dalio

Founder of Bridgewater Associates

“There is nothing to fear from the truth... Being truthful, and letting others be truthful with you, allows you to explore your own thoughts and the thoughts of others, which is essential for learning.”

Ray Dalio

Founder of Bridgewater Associates

How we work

Our business is guided by two simple principles

Our business is guided by two simple principles

  1. We strive to give our customers the information we'd want if our roles were reversed.

  2. We only publish analysts whose advice and strategies we'd want our own families to read and to follow.

01

Identify The Atlas Rank

Buy, Sell or Hold

We analyze the entire market mathematically to give you a clear, unbiased "Buy," "Sell," or "Hold" rating on any stock in your portfolio.

01

Assessment

Buy, Sell or Hold

We analyze the entire market mathematically to give you a clear, unbiased "Buy," "Sell," or "Hold" rating on any stock in your portfolio.

01

Identify The Atlas Rank

Buy, Sell or Hold

We analyze the entire market mathematically to give you a clear, unbiased "Buy," "Sell," or "Hold" rating on any stock in your portfolio.

02

Predict Earnings ESP & Price Response.

Forecasts

We forecast the "invisible" moves Wall Street misses. You get the probability of an earnings beat and a price target before the rest of the market reacts.

02

Predict Earnings ESP & Price Response.

Forecasts

We forecast the "invisible" moves Wall Street misses. You get the probability of an earnings beat and a price target before the rest of the market reacts.

02

Predict Earnings ESP & Price Response.

Forecasts

We forecast the "invisible" moves Wall Street misses. You get the probability of an earnings beat and a price target before the rest of the market reacts.

03

Capitalize Pharma Fortunes

10x calls

We hunt for the rare 10x opportunities. You receive exclusive dossiers on biotech stocks in Pharma Fortunes.

03

Capitalize Pharma Fortunes

10x calls

We hunt for the rare 10x opportunities. You receive exclusive dossiers on biotech stocks in Pharma Fortunes.

03

Capitalize Pharma Fortunes

10x calls

We hunt for the rare 10x opportunities. You receive exclusive dossiers on biotech stocks in Pharma Fortunes.

Why choose us

The Wall Street "Rebels"

The Wall Street "Rebels"

Atlas Publishing is not for passive tourists; it is for active investors. Whether you are looking for the steady compounding of the Atlas Rank or the potential 10x of Pharma Fortunes, our specialized research services arm you with the "unfair advantage" you need to win.

Atlas Publishing is not for passive tourists; it is for active investors. Whether you are looking for the steady compounding of the Atlas Rank or the potential 10x of Pharma Fortunes, our specialized research services arm you with the "unfair advantage" you need to win.

Our Mission

At Atlas, we do things differently. We don't follow the herd, and we don't listen to the mainstream media.

  • We prove that you can beat Wall Street at its own game.

  • We empower you to achieve financial freedom without paying 2% fees to a manager who underperforms the market.

  • We focus on data, not narratives—helping you build a dynasty of wealth through independent research.

  • We know that the best person to secure your retirement is you.

At Atlas, we do things differently. We don't follow the herd, and we don't listen to the mainstream media.

  • We prove that you can beat Wall Street at its own game.

  • We empower you to achieve financial freedom withoutpaying2% fees to a manager who underperforms the market.

  • We focus on data, not narratives—helping you build a dynasty of wealth through independent research.

  • We know that the best person to secure your retirement is you.


The Problem

Other agencies

They overwhelm you with buzzwords, charge fees regardless of performance, and sell generic strategies that fail to beat the market.

They overwhelm you with buzzwords, charge fees regardless of performance, and sell generic strategies that fail to beat the market.


The Solution

Atlas Publishing Co.

At Atlas, we use proven math, deliver clear "Buy/Sell" signals, and give you the institutional tools to outperform the pros from day one.

At Atlas, we use proven math, deliver clear "Buy/Sell" signals, and give you the institutional tools to outperform the pros from day one.

"Math vs. Fee Advisors"

We value math over opinions.

Wall Street runs on fees, gut feelings, and fearmongering. We run on cold, hard math. We use the same data sets relied on since 1988.

At Atlas our Rank system has ignored the noise and focused on the only metric that matters: earnings estimate revisions.

The "experts" were wrong about the Dot-Com crash, the 2008 crisis, and and countless 10x biotech and pharma wins.

Our algorithms quietly signaling the right moves—delivering editorial for returns that doubled the market average.

23%

Data we rely on delivered 23% Avg. Annual Gain Since 1988

2x

2x The S&P 500 Performance benchmark


Atlas

Atlas Publishing Co.

Data you can rely on

Defense-Grade Tech + Decades of Data.

We don’t run on guesswork. We leverage the same AI architecture trusted by U.S. defense and intelligence agencies to process complex scenarios.

But AI is only as powerful as the data you feed it. That’s why we power our systems with a proprietary financial engine built in 1978. We aggregate real-time EPS estimates from over 3,000 analysts across 180 major brokerages. Our data isn't just deep—it’s bulletproof.

But AI is only as powerful as the data you feed it. That’s why we power our systems with a proprietary financial engine built in 1978. We aggregate real-time EPS estimates from over 3,000 analysts across 180 major brokerages. Our data isn't just deep—it’s bulletproof.

Want the unfair advantage?

Stop guessing and start knowing. Subscribe today to unlock the Atlas Rank and get the "Silent Signal" on the three stocks poised to explode this week.

Stop guessing and start knowing. Subscribe today to unlock the Atlas Rank and get the "Silent Signal" on the three stocks poised to explode this week.

Pricing

Flexible Plan for Every Stage.

Flexible Plan for
Every Stage.

Fund Fortunes

Contact for Flexible Pricing

Essential insights for building your wealth with smart, foundational fund strategies.

1 connected account

Real-time dashboard access

Basic reporting

Email support

Up to 2,000 API call usage for the Atlas AI + Seats

Fund Fortunes

Contact for Flexible Pricing

Essential insights for building your wealth with smart, foundational fund strategies.

1 connected account

Real-time dashboard access

Basic reporting

Email support

Up to 2,000 API call usage for the Atlas AI + Seats

Fund Fortunes

Contact for Flexible Pricing

Essential insights for building your wealth with smart, foundational fund strategies.

1 connected account

Real-time dashboard access

Basic reporting

Email support

Up to 2,000 API call usage for the Atlas AI + Seats

Best Deal

Pharma Fortunes

Contact for Flexible Pricing

Ideal for investors targeting high-growth opportunities in the dynamic pharmaceutical sector.

Up to 5 connected accounts

Advanced analytics

Automated reports

Priority email support

Up to 10,000 API call usage for the Atlas AI + Seats

Best Deal

Pharma Fortunes

Contact for Flexible Pricing

Ideal for investors targeting high-growth opportunities in the dynamic pharmaceutical sector.

Up to 5 connected accounts

Advanced analytics

Automated reports

Priority email support

Up to 10,000 API call usage for the Atlas AI + Seats

Best Deal

Pharma Fortunes

Contact for Flexible Pricing

Ideal for investors targeting high-growth opportunities in the dynamic pharmaceutical sector.

Up to 5 connected accounts

Advanced analytics

Automated reports

Priority email support

Up to 10,000 API call usage for the Atlas AI + Seats

Platinum VIP

Contact for Flexible Pricing

The ultimate bundle: Pharma Fortunes, Fund Fortunes, and 10x Stocks. Maximize your portfolio's potential.

Unlimited connected accounts

Custom dashboards

Exportable reports

Dedicated support

Unlimited API call usage for the Atlas AI + Seats

Platinum VIP

Contact for Flexible Pricing

The ultimate bundle: Pharma Fortunes, Fund Fortunes, and 10x Stocks. Maximize your portfolio's potential.

Unlimited connected accounts

Custom dashboards

Exportable reports

Dedicated support

Unlimited API call usage for the Atlas AI + Seats

Platinum VIP

Contact for Flexible Pricing

The ultimate bundle: Pharma Fortunes, Fund Fortunes, and 10x Stocks. Maximize your portfolio's potential.

Unlimited connected accounts

Custom dashboards

Exportable reports

Dedicated support

Unlimited API call usage for the Atlas AI + Seats

Over 18,000+ Readers Of Atlas

Get access to the world’s most valuable market insights

Join today for less than the cost of a cup of coffee and see exactly where our Atlas AI predicts the next market explosion.

Over 18,000+ Readers Of Atlas

Get access to the world’s most valuable market insights

Join today for less than the cost of a cup of coffee and see exactly where our Atlas AI predicts the next market explosion.

Over 18,000+ Readers Of Atlas

Get access to the world’s most valuable market insights

Join today for less than the cost of a cup of coffee and see exactly where our Atlas AI predicts the next market explosion.

FAQ

Your questions answered.

Everything you need to know about working with us. Still have questions? Book a free call and we'll walk you through it.

How much does a subscription cost?

We believe elite research should be accessible to everyone. We offer a robust FREE Share Advisor service for beginners. For serious winners, our premium institutional-grade research tops out at just $3 a day—less than a cup of coffee for the same data hedge funds pay millions for. Book a call to find the best fit for you.

What if the market crashes?

Our systems are built for all weather. The Atlas Rank data helped subscribers navigate the Dot-Com bust and the 2008 crisis. We don't just teach you how to make money when stocks go up; we show you how to protect it when they go down.

How is this different from a financial advisor?

Two major differences: Control and Cost. We don't touch your money, and we don't charge fees on it. We don’t give your personalized advice either. We give you the intelligence to manage your own money and keep 100% of your gains. Think of us as your Pentagon that gives valuable intel to your field generals.

Do I need a big portfolio?

Absolutely not. Our PhD-level algorithms do complex math so you don't have to. We boil millions of data points down to simple, actionable signals: "Buy," "Sell," or "Hold." If you can click a mouse, you can use Atlas.

Is there a lock-in contract?

No. We offer a limited money back guarantee after the trial period. In addition, all the upside is obviously yours. You can leave anytime and your portfolio is not connected to our data.

How quickly will I see results?

Investing is a long-term game, but our tools work instantly. The moment you sign up, you can run your current portfolio through the Atlas Rank to spot weak stocks immediately. Strategies like Pharma Fortunes are event-driven and can produce results in days or weeks.

Why is your pricing so low compared to the value?

Because we are a publisher, not a brokerage or hedge fund. Fund typically take 20% of your upside and a 2% management fee. By serving thousands of subscribers, we can democratize access to this military-grade AI.

Do you trade the stocks you recommend?

We have strict ethical guidelines. Our primary goal is your success. We are independent publishers with no hidden agendas, investment banking conflicts, or "pump and dump" schemes. That’s to say, we do NOT trade them or we would have a vested interest. All the upside is yours.

Can I start with a small account?

Yes. In fact, our strategy is perfect for growing accounts. Because we focus on percentage gains (like the 1,000% potential in biotech), you don't need a million dollars to see life-changing returns. You just need the right information.

Where are you located?

In DC, NY, and London. We operate from the hearts of the financial world to ensure we are always where the decisions are being made.

Are you affiliated with any brokerage or bank?

Never. We are 100% independent. We do not accept commissions, kickbacks, or payment for order flow. Unlike "free" apps (like Robinhood) that sell your data to hedge funds, we work exclusively for you.

How often is the data updated?

Daily. The market never sleeps, and neither do our algorithms. The Atlas Rank and earnings estimates are recalculated every single night, ensuring you start every trading day with the freshest intelligence available.

FAQ

Your questions answered.

Everything you need to know about working with us. Still have questions? Book a free call and we'll walk you through it.

How much does a subscription cost?

We believe elite research should be accessible to everyone. We offer a robust FREE Share Advisor service for beginners. For serious winners, our premium institutional-grade research tops out at just $3 a day—less than a cup of coffee for the same data hedge funds pay millions for. Book a call to find the best fit for you.

What if the market crashes?

Our systems are built for all weather. The Atlas Rank data helped subscribers navigate the Dot-Com bust and the 2008 crisis. We don't just teach you how to make money when stocks go up; we show you how to protect it when they go down.

How is this different from a financial advisor?

Two major differences: Control and Cost. We don't touch your money, and we don't charge fees on it. We don’t give your personalized advice either. We give you the intelligence to manage your own money and keep 100% of your gains. Think of us as your Pentagon that gives valuable intel to your field generals.

Do I need a big portfolio?

Absolutely not. Our PhD-level algorithms do complex math so you don't have to. We boil millions of data points down to simple, actionable signals: "Buy," "Sell," or "Hold." If you can click a mouse, you can use Atlas.

Is there a lock-in contract?

No. We offer a limited money back guarantee after the trial period. In addition, all the upside is obviously yours. You can leave anytime and your portfolio is not connected to our data.

How quickly will I see results?

Investing is a long-term game, but our tools work instantly. The moment you sign up, you can run your current portfolio through the Atlas Rank to spot weak stocks immediately. Strategies like Pharma Fortunes are event-driven and can produce results in days or weeks.

Why is your pricing so low compared to the value?

Because we are a publisher, not a brokerage or hedge fund. Fund typically take 20% of your upside and a 2% management fee. By serving thousands of subscribers, we can democratize access to this military-grade AI.

Do you trade the stocks you recommend?

We have strict ethical guidelines. Our primary goal is your success. We are independent publishers with no hidden agendas, investment banking conflicts, or "pump and dump" schemes. That’s to say, we do NOT trade them or we would have a vested interest. All the upside is yours.

Can I start with a small account?

Yes. In fact, our strategy is perfect for growing accounts. Because we focus on percentage gains (like the 1,000% potential in biotech), you don't need a million dollars to see life-changing returns. You just need the right information.

Where are you located?

In DC, NY, and London. We operate from the hearts of the financial world to ensure we are always where the decisions are being made.

Are you affiliated with any brokerage or bank?

Never. We are 100% independent. We do not accept commissions, kickbacks, or payment for order flow. Unlike "free" apps (like Robinhood) that sell your data to hedge funds, we work exclusively for you.

How often is the data updated?

Daily. The market never sleeps, and neither do our algorithms. The Atlas Rank and earnings estimates are recalculated every single night, ensuring you start every trading day with the freshest intelligence available.

FAQ

Your questions answered.

Everything you need to know about working with us. Still have questions? Book a free call and we'll walk you through it.

How much does a subscription cost?

We believe elite research should be accessible to everyone. We offer a robust FREE Share Advisor service for beginners. For serious winners, our premium institutional-grade research tops out at just $3 a day—less than a cup of coffee for the same data hedge funds pay millions for. Book a call to find the best fit for you.

What if the market crashes?

Our systems are built for all weather. The Atlas Rank data helped subscribers navigate the Dot-Com bust and the 2008 crisis. We don't just teach you how to make money when stocks go up; we show you how to protect it when they go down.

How is this different from a financial advisor?

Two major differences: Control and Cost. We don't touch your money, and we don't charge fees on it. We don’t give your personalized advice either. We give you the intelligence to manage your own money and keep 100% of your gains. Think of us as your Pentagon that gives valuable intel to your field generals.

Do I need a big portfolio?

Absolutely not. Our PhD-level algorithms do complex math so you don't have to. We boil millions of data points down to simple, actionable signals: "Buy," "Sell," or "Hold." If you can click a mouse, you can use Atlas.

Is there a lock-in contract?

No. We offer a limited money back guarantee after the trial period. In addition, all the upside is obviously yours. You can leave anytime and your portfolio is not connected to our data.

How quickly will I see results?

Investing is a long-term game, but our tools work instantly. The moment you sign up, you can run your current portfolio through the Atlas Rank to spot weak stocks immediately. Strategies like Pharma Fortunes are event-driven and can produce results in days or weeks.

Why is your pricing so low compared to the value?

Because we are a publisher, not a brokerage or hedge fund. Fund typically take 20% of your upside and a 2% management fee. By serving thousands of subscribers, we can democratize access to this military-grade AI.

Do you trade the stocks you recommend?

We have strict ethical guidelines. Our primary goal is your success. We are independent publishers with no hidden agendas, investment banking conflicts, or "pump and dump" schemes. That’s to say, we do NOT trade them or we would have a vested interest. All the upside is yours.

Can I start with a small account?

Yes. In fact, our strategy is perfect for growing accounts. Because we focus on percentage gains (like the 1,000% potential in biotech), you don't need a million dollars to see life-changing returns. You just need the right information.

Where are you located?

In DC, NY, and London. We operate from the hearts of the financial world to ensure we are always where the decisions are being made.

Are you affiliated with any brokerage or bank?

Never. We are 100% independent. We do not accept commissions, kickbacks, or payment for order flow. Unlike "free" apps (like Robinhood) that sell your data to hedge funds, we work exclusively for you.

How often is the data updated?

Daily. The market never sleeps, and neither do our algorithms. The Atlas Rank and earnings estimates are recalculated every single night, ensuring you start every trading day with the freshest intelligence available.